The company's debt usage and EBIT loss over the past year, s...
The company's debt usage and EBIT loss over the past year, slow revenue growth, weak balance sheet, and cash burn rate all contribute to the stock's perceived riskiness, despite potential for future improvement.
Shenzhen Chipscreen Biosciences (SHSE:688321) Is Making Moderate Use Of Debt
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment